Graviola: The Rainforest's Green Heart

Ancient Lore, Indigenous Wisdom & Modern Science

A Tree That Wears Its Names Like Armor

Annona muricata — known to the world as graviola, guanábana, soursop, corossol, sirsak, guyabano, or Brazilian pawpaw — is one of the most named plants on earth. Every culture that has encountered it has had something urgent to say, and has needed its own word to say it. It is known as guayabano in the Philippines; guanabana in Spanish; corossol épineux in French; sirsak in Indonesian; graviola in Portuguese; thurian thet in Thailand; mang cau xiem in Vietnamese; and durian belanda in Malaysia.

In Spanish-speaking Latin America it is most commonly guanábana — a name whose roots are disputed, possibly Taíno, the language of the indigenous Caribbean peoples who inhabited the islands that Columbus first encountered. In Peru and much of the Andean world, both names circulate: graviola (from the Portuguese, carried by trade and migration) and guanábana (the regional Spanish). In the Quechua-speaking communities of the Amazon and its edges, the tree is known simply as a healing plant of the lowlands — shapaja in some dialects, or described by its fruit — and healers from the high jungle have long incorporated it into the broader Andean pharmacopeia, where plants are classified not merely by species but by their energetic quality, their temperature (hot, cold, neutral), and their alignment with the spiritual forces of Pachamama.

The name soursop is derived from the Dutch word zuurzak, which translates to "sour sack." The English name captures only the flavor. The other names capture something deeper — the strangeness of the fruit's exterior, the sweetness hiding beneath its armored, spike-studded green skin.

Botanical Identity: The Spined Green Heart

Annona muricata is an evergreen, terrestrial, erect tree reaching 5 to 8 meters in height, featuring an open, roundish canopy with large, glossy, dark green leaves. The edible fruits of the tree are large, heart-shaped, and green in color, with a diameter varying between 15 and 20 cm.

Soft, curved spines cover the leathery skin of the fruits, each of which may contain 55 to 170 black seeds distributed in a creamy white flesh with a characteristic aroma and flavor. The flavor is famously difficult to describe — something like a marriage of pineapple, mango, strawberry, and coconut, with a faint tartness that gives it its sour name. It is at once tropical and singular, unlike anything else, the kind of fruit that people who have tasted it remember vividly for the rest of their lives.

Annona muricata probably originated in the Antilles in the Caribbean and is cultivated in many countries such as Angola, Brazil, Colombia, Costa Rica, Cuba, and Jamaica. From the Caribbean it moved with indigenous peoples, trade routes, and eventually with the Spanish and Portuguese into South America, Africa, Southeast Asia, and Polynesia — finding fertile ground in every humid tropical zone it encountered, and being absorbed into every medical tradition it met.

Ancient and Indigenous Use: The Whole Tree as Medicine

Few plants offer themselves as completely to human healing as graviola. Every part of it — the leaves, bark, roots, seeds, fruit pulp, and fruit skin — has been used medicinally by indigenous and traditional cultures across multiple continents, often for overlapping conditions, arrived at through entirely separate traditions of observation.

The leaves, bark, and roots of the tree, along with the seeds of the fruit, have been used by indigenous cultures and in folk medicine for centuries. Tribal cultures have respected and used basically all parts of the tree and fruit as part of their healing traditions. Ethnomedical uses of graviola by indigenous peoples include diarrhea, headaches, parasites, childbirth, abscesses, dysentery, edema, heart conditions, fever, skin conditions, indigestion, inflammation, depression, hypertension, asthma, nervousness, fungal infections, malaria, kidney problems, and use as a sedative.

The inhabitants of the Peruvian Andes make tea from graviola leaves for catarrh — inflammation of the mucous membranes — and eat crushed seeds to kill parasites and bacteria. The Peruvian Amazon tribes consider the roots, leaves, and bark of the tree to have sedative and antispasmodic properties. The population of the Brazilian Amazon has always used graviola leaf tea to treat liver problems.

The bark and leaves were praised for their antispasmodic and sedative properties and effectiveness for treating heart diseases, cough, flu, asthma, and hypertension. Indigenous tribes of the rainforest scattered the crushed leaves around beds and pillowcases to promote good sleep. The crushed leaves were also used instead of smelling salts to return consciousness.

The image of crushed graviola leaves placed beneath a sleeping person's pillow to induce rest speaks to a level of intimate botanical knowledge that comes only from generations of daily living with a plant — watching it, tasting it, testing it in sickness and in health, and understanding not just what it does in extremity but how it shapes the texture of ordinary life. This is not superstition. It is the accumulated pharmacology of communities without laboratories, conducted across centuries of direct human observation.

In the Peruvian Andes, graviola leaves are used to combat parasites and treat diabetes. In the Peruvian Andes, a leaf tea is used for catarrh and the crushed seed is used to kill parasites.

The Spanish Colonial Record and the First Documentation

The Spanish encountered the guanábana tree early in their colonization of the Caribbean and Central America, and quickly recognized it as extraordinary. Indigenous peoples of the Caribbean and Central America were among the first to cultivate and utilize soursop for its culinary and wellness properties. They valued the fruit and leaves not only for taste but also for their versatility in various traditional uses.

Spanish historian Gonzalo Fernández de Oviedo, one of the first European chroniclers of New World natural history, documented the guanábana tree in the early sixteenth century, describing both its remarkable fruit and its medical applications among the indigenous peoples he encountered. The plant traveled quickly across Spanish colonial networks — to the Philippines, to West Africa, to Southeast Asia — carried by the same ships that carried silver, spices, and enslaved people across the Pacific and Atlantic. By the time colonial botanists began systematically cataloguing tropical medicinal plants in the seventeenth and eighteenth centuries, graviola was already established across four continents, being used in remarkably consistent ways by peoples who had never met.

The Chemistry: Acetogenins, Alkaloids & Flavonoids

What makes graviola leaves biochemically unique — and what has driven the most intense scientific interest — is a class of compounds found nowhere else in the plant kingdom: annonaceous acetogenins, which are the major constituents of Annona muricata. More than 100 annonaceous acetogenins have been isolated from leaves, barks, seeds, roots, and fruits of A. muricata.

Annonaceous acetogenins are derivatives of long-chain C35 to C37 fatty acids biosynthesized via the polyketide pathway. Several of these acetogenins exert cytotoxicity via inhibiting mitochondrial complex I, which is involved in ATP synthesis. It was rationalized that acetogenins could specifically inhibit growth of cancer cells that usually have a higher demand for ATP compared to normal cells.

In other words, graviola's signature compounds target the energy metabolism of cells — and since cancer cells consume energy at a dramatically higher rate than healthy cells, there is a theoretical selectivity built into the mechanism. The cancer cell's hunger is, in a sense, its vulnerability.

Intensive pharmacological studies identified almost 200 phytochemicals, mostly acetogenins and alkaloids from A. muricata. In A. muricata leaf extract, alkaloids such as anomurine, reticuline, and coreximine are present, alongside essential oil constituents.

Phytochemical analysis of graviola leaves has revealed a richness of phenolic compounds, including gallic acid, catechin, quercetin, and rutin. The extract exhibits strong antioxidant capacity in both DPPH and FRAP assays. These flavonoids — quercetin and rutin in particular — are among the most studied anti-inflammatory and antioxidant compounds in natural medicine, appearing also in green tea, elderberries, and many other medicinal plants. In graviola, they work alongside the acetogenins, creating a pharmacological matrix of considerable complexity.

The National Cancer Institute Discovery and the Research Explosion

Interest in graviola as a potential anticancer agent surged following the discovery of its cytotoxic property in a 1976 plant-screening program by the National Cancer Institute. Annonaceous acetogenins, extracted from different parts of the tree, were found to have cytotoxic effects.

What followed was one of the most intensive periods of natural products research directed at a single tropical plant. Laboratories in the United States, Brazil, Japan, Malaysia, Taiwan, and India spent decades systematically isolating, characterizing, and testing graviola's acetogenins against cancer cell lines.

The reported therapeutic benefits of graviola against various human tumors and disease agents in in vitro culture and preclinical animal model systems are typically tested for their ability to specifically target the disease, while exerting little or no effect on normal cell viability.

Lab studies have evaluated extracts from the graviola leaf, fruit, and seed for their anticancer effects. Some of these studies suggest activity against breast, lung, colon, prostate, pancreatic, liver, and skin cancer cell lines.

A study on triple negative breast cancer — one of the most treatment-resistant forms — found a significant decrease in breast cancer cells' viability after 48-hour incubation with increasing concentrations of graviola leaf extract. Annonaceous acetogenins, including annonacin isomers, were identified as characteristic compounds using liquid chromatography tandem mass spectrometry.

Anti-cancer activity studies done for breast cancer cell lines MCF-7 showed a cell inhibition activity of 98%. In vitro, under laboratory conditions — a striking number, though one that must be understood in its proper context: in vitro results do not automatically translate to human clinical outcomes.

The most potent leishmanicidal compound against all three Leishmania species tested was the acetogenin annonacinone. Additionally, graviola extract was found to be as effective against the dental root canal pathogen Enterococcus faecalis in vitro as sodium hypochlorite (1% bleach) — providing a possible alternative for root canal irrigation.

Anticancer Mechanisms: How It Works

Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells, reducing their proliferation and clonogenicity. Treatment strongly inhibited hypoxia-induced NOX activity in prostate cancer cells, associated with a decrease in the expression of NOX catalytic and regulatory subunits.

The significance of this finding is considerable. Tumor hypoxia — the low-oxygen environment that cancer cells create and exploit — is one of the key drivers of cancer progression, metastasis, and resistance to treatment. A compound that interferes with the cancer cell's adaptation to hypoxic conditions is interfering with one of cancer's most powerful survival strategies.

Over 100 different types of acetogenins have been extracted from the leaves, bark, seeds, roots, and fruits of graviola. A clinical study conducted on a 66-year-old patient suffering from metastatic breast cancer showed that the consumption of graviola leaves boiled in water stopped the progression of chemotherapeutic-resistant metastatic tumors. Graviola extracts have ever since been prescribed in adjuvant therapy.

Graviola extracts and their constituents, individually or in combination, have shown therapeutic properties for other ailments including chronic inflammatory and oxidative diseases, wounds, and noninfectious and infectious microbial and parasitic diseases. Benefits thus far reported for graviola constituents have included anxiolytic, anticancer, antitumorigenic, antidepressant, gastroprotective, antimalarial, antinociceptive, immunomodulatory, antistress, and wound healing activities.

Beyond Cancer: A Broad Spectrum of Healing

The intense focus on graviola's anticancer properties risks overshadowing the breadth of its pharmacological profile — a range of activities that traditional healers have been deploying for centuries and that modern research is steadily confirming.

In animal models, graviola extracts showed anti-inflammatory, analgesic, antidiabetic, antiulcer, and antiviral effects. The leaf extracts also have antimicrobial activities.

The antidiabetic activity of Annona muricata is due to the antioxidant properties contained in the fruits and leaves, as well as flavonoids that inhibit the activity of α-glucosidase, suppressing carbohydrate hydrolysis and glucose absorption and inhibiting carbohydrate metabolism into glucose. The anti-diarrheal activity is attributed to flavonoids, triterpenoids, and saponins which play a role by inhibiting intestinal motility and secretions that cause diarrhea. Research has shown that extracts from the fruit and leaves have antihypertensive properties, notably by lowering blood pressure.

Graviola leaves are traditionally used to treat gastrointestinal disorders, parasitic infections, joint pain, inflammatory diseases, respiratory conditions, and fever. Ethnobotanical data also support their use as a sedative, insecticide, antiparasitic, and in the treatment of malaria, as well as liver and kidney conditions.

Graviola has also been shown to stimulate serotonin receptors. This finding is pharmacologically significant: serotonin receptor activity is associated with mood regulation, anxiety reduction, and the calming effect that traditional healers have long attributed to graviola leaf tea. The grandmother who brewed graviola leaves for a sleepless child was, without knowing it, administering a serotonergic herb.

The Shadow: Neurotoxicity and the Annonacin Question

Graviola's extraordinary power comes with a shadow that must be honestly addressed. The same acetogenins that give it anticancer potential are also neurotoxic in high doses.

An in vitro study on Lund human mesencephalic neurons showed that a dose of 1 μg/mL of graviola pulp extract induced death in 67% of the neurons. Similarly, annonacin, the major acetogenin of graviola, impairs energy production in neurons by inhibiting the mitochondrial respiratory chain complex I. The study showed that annonacin is toxic to dopaminergic neurons at very low doses, and its consumption might be associated with forms of Parkinsonism.

A consensus was reached in 2010 that consumption of species of Annonaceae was not directly related to occurrence of atypical parkinsonism. However, other toxicologic findings nevertheless merit serious consideration, such that future studies of graviola components must include rigorous safety testing, since the content of potential toxins could vary according to the part of the plant, the extraction method, the location where the plant is grown, and even the time of harvest.

This nuance is precisely the kind of thing traditional knowledge systems encode in their dosage and preparation instructions — which parts to use, how much, for how long, and in what combination with other plants. The Andean and Amazonian healers who used graviola leaves as a tea rather than a concentrated extract, who cycled its use rather than consuming it daily for years, who combined it with other herbs in formulas designed for balance — were practicing a pharmacology of moderation that the enthusiasm for isolated compounds can easily bypass.

Despite lack of substantial clinical evidence, graviola is heavily promoted as a cancer-fighting herb. This promotion — often extravagant and irresponsible — has outpaced the science, leading to patients abandoning conventional treatment for a plant whose clinical evidence base, while promising, remains largely at the preclinical stage. The plant deserves better advocates — ones who can hold both its genuine promise and its genuine risks with equal honesty.

Graviola Leaves as Daily Medicine: The Andean and Amazonian Practice

In the markets of Lima, Iquitos, Bogotá, and Caracas, dried graviola leaves are sold in bundles alongside other medicinal herbs, often by vendors who have been preparing and prescribing them for decades. The most common preparation is a simple tea: five to seven leaves simmered in water for ten to fifteen minutes, strained, and drunk warm — sometimes with honey or lemon. This is the preparation used by generations of Amazonian and Andean families for fever, high blood pressure, insomnia, stomach upset, and general wellbeing.

A recent descriptive and cross-sectional questionnaire identified graviola as the most popular herbal remedy in Trinidad, used for prostate, breast, and colorectal cancer patients. In the Caribbean, in West Africa, in Southeast Asia, in South America — wherever this tree took root, the leaves became medicines. The pattern of use across these geographically separated traditions, arriving at the same preparations and the same applications without any shared medical literature, is the kind of convergent ethnopharmacology that demands scientific attention.

The Forest That Holds the Cure

There is a quality about graviola that resists easy categorization. It is simultaneously food and medicine, sacred and quotidian, a fruit vendor's stock and a cancer researcher's focus. Its heart-shaped fruit, green and spiked like a vegetable crown, grows directly from the tree's trunk and branches — a botanical quirk called cauliflory that makes it look as though the tree is offering its heart directly, without pretense.

Various extracts from the plant have been used as traditional herbal medicine and have proved to possess a broad range of properties, including antioxidant, anti-inflammatory, antiarthritic, hepatoprotective, gastroprotective, antidiabetic, antimalarial, antibacterial, antiprotozoan, insecticidal, larvicidal, and healing of wounds.

The Amazonian rainforest in which graviola evolved is itself a vast pharmacy — the most biodiverse ecosystem on earth, containing an estimated ten percent of all species, the majority of which have never been studied by Western science. Acetogenins and other secondary metabolites, including alkaloids, of this plant possess demonstrable ability to decrease growth of cancer that could be further comprehensively exploited. Acetogenins or other Annona muricata-derived compounds could be tested as monotherapy or as sensitizers.

The urgency is real. Every year of rainforest destruction is a year of irreplaceable pharmacological knowledge lost — not just the plants themselves, but the indigenous knowledge systems that understand how to use them safely, in context, in relationship with the other plants and practices that make them medicine rather than just chemistry.

Conclusion: The Armored Heart of the Forest

Graviola's spiked green exterior is an almost too perfect metaphor for the plant itself: defended on the outside, extraordinary within. Its leaves, dark and glossy, unremarkable to the eye, contain within them a chemistry that has drawn the attention of the National Cancer Institute, of oncology researchers on three continents, and of the indigenous healers of the Amazon who have understood them, in their own vocabulary, for as long as anyone can remember.

The traditional ethnobotanical usage of soursop leaves spans several continents including Africa, South America, and parts of Asia, where indigenous communities have long relied on its natural bioactive compounds for treating ailments such as cancer, inflammation, diabetes, hypertension, and various infectious diseases.

Whether it will ultimately yield a pharmaceutical breakthrough — a refined acetogenin, bioavailable and targeted, safe for human clinical use — remains to be established by the clinical trials that are only now beginning in earnest. What is already established is that the people of the Amazon, the Caribbean, West Africa, and Southeast Asia were not wrong. They found in this tree something real. They encoded it in their medicine and passed it down through generations, in the patient, cumulative way that traditional knowledge is always built — not with grants and publications, but with observation, care, and the long memory of people who cannot afford to be wrong about the plants they depend on.

The armored green heart of the rainforest has been offering itself for a very long time. Science is only now learning how to receive what it gives.